National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Insulin aspart (Fiasp®) is indicated for the treatment of diabetes mellitus in adults.

 

Rapid Review

Commenced Completed Outcome
17/05/2017 14/06/2017 Full Pharmacoeconomic Evaluation Not Recommended